Intracranial Stents Total Addressable Market Size, Share & Trends Analysis Report By Application (Intracranial Stenosis, Brain Aneurysm), By Product, By End User, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.2.1. Information Procurement
1.3. Information or Data Analysis
1.4. Methodology
1.5. Research Scope and Assumptions
1.6. Market Formulation & Validation
1.6.1. COUNTRY MARKET: CAGR CALCULATION
1.7. Country Based Segment Share Calculation
1.8. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional Insights
2.4. Competitive Insights
2.5. Intracranial Stents Total Addressable Market Snapshot
2.6. Intracranial Stents Total Addressable Market Segment Snapshot
2.7. Intracranial Stents Total Addressable Market Competitive Landscape Snapshot
Chapter 3. Intracranial Stents Total Addressable Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Intracranial Stents Total Addressable Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Bargaining power of the suppliers
3.3.1.2. Bargaining power of the buyers
3.3.1.3. Threats of substitution
3.3.1.4. Threats from new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.4. Product Pipeline Analysis
3.5. Estimated Number of cases requiring intracranial stenting at global and regional levels
3.6. Estimated Cost of Procedure by Application
3.7. Total estimated number of units sold at global and regional levels
3.8. Estimated ASPs by product segments at global and regional levels (2021)
3.9. Impact of COVID-19 on Intracranial Stents Total Addressable Market
Chapter 4. Intracranial Stents Total Addressable Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Intracranial Stents Total Addressable Market: Product Movement Analysis, USD Million, 2022 & 2030
4.3. Embolization Coil Support Intracranial Stents
4.3.1. Embolization Coil Support Intracranial Stents Total Addressable Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.4. Self-Expanding Stents
4.4.1. Self-Expanding Stents Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.5. Others
4.5.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.5.2. Venous Sinus Stents
4.5.2.1. Venous Sinus Stents Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.5.3. Balloon-expanding & Other Stents
4.5.3.1. Balloon-expanding & Other Stents Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
4.5.4. Prescriptive Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 5. Intracranial Stents Total Addressable Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Intracranial Stents Total Addressable Market: Application Movement Analysis, USD Million, 2022 & 2030
5.3. Intracranial Stenosis
5.3.1. Intracranial Stenosis Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.4. Brain Aneurysm
5.4.1. Brain Aneurysm Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
5.5.不hers
5.5.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 6. Intracranial Stents Total Addressable Market: End user Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Intracranial Stents Total Addressable Market: End user Movement Analysis, USD Million, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
6.4. Ambulatory Surgical Centers
6.4.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 7. Intracranial Stents Total Addressable Market: Regional Estimates & Trend Analysis
7.1. Intracranial Stents Total Addressable Market: Regional Movement Analysis, 2022 & 2030
7.2. North America
7.2.1. North America Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Prevalence Insights
7.2.2.3. Regulatory Framework
7.2.2.4. Reimbursement Structure
7.2.2.5. U.S. Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Prevalence Insights
7.2.3.3. Regulatory Framework
7.2.3.4. Reimbursement Structure
7.2.3.5. Canada Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3. Europe
7.3.1. Europe Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Prevalence Insights
7.3.2.3. Regulatory Framework
7.3.2.4. Reimbursement Structure
7.3.2.5. UK Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Prevalence Insights
7.3.3.3. Regulatory Framework
7.3.3.4. Reimbursement Structure
7.3.3.5. Germany Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Prevalence Insights
7.3.4.3. Regulatory Framework
7.3.4.4. Reimbursement Structure
7.3.4.5. France Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Prevalence Insights
7.3.5.3. Regulatory Framework
7.3.5.4. Reimbursement Structure
7.3.5.5. Italy Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Prevalence Insights
7.3.6.3. Regulatory Framework
7.3.6.4. Reimbursement Structure
7.3.6.5.西班牙总Addressab颅内支架le Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Prevalence Insights
7.3.7.3. Regulatory Framework
7.3.7.4. Reimbursement Structure
7.3.7.5. Denmark Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Prevalence Insights
7.3.8.3. Regulatory Framework
7.3.8.4. Reimbursement Structure
7.3.8.5. Sweden Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Prevalence Insights
7.3.9.3. Regulatory Framework
7.3.9.4. Reimbursement Structure
7.3.9.5. Norway Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Prevalence Insights
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Structure
7.4.2.5. Japan Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Prevalence Insights
7.4.3.3. Regulatory Framework
7.4.3.4.补偿结构
7.4.3.5. China Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Prevalence Insights
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Structure
7.4.4.5. India Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. Key Country Dynamics
7.4.5.2. Prevalence Insights
7.4.5.3. Regulatory Framework
7.4.5.4. Reimbursement Structure
7.4.5.5. South Korea Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Key Country Dynamics
7.4.6.2. Prevalence Insights
7.4.6.3. Regulatory Framework
7.4.6.4. Reimbursement Structure
7.4.6.5. Australia Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Prevalence Insights
7.4.7.4. Regulatory Framework
7.4.7.5. Reimbursement Structure
7.4.7.6. Thailand Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Prevalence Insights
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Structure
7.5.2.5. Brazil Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Prevalence Insights
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Structure
7.5.3.5. Mexico Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Prevalence Insights
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Structure
7.5.4.5. Argentina Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.6. Middle East & Africa
7.6.1. Middle East & Africa Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Prevalence Insights
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Structure
7.6.2.5. South Africa Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Prevalence Insights
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Structure
7.6.3.5. Saudi Arabia Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Prevalence Insights
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Structure
7.6.4.5. UAE Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Prevalence Insights
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Structure
7.6.5.5. Kuwait Intracranial Stents Total Addressable Market Estimates And Forecasts, 2017 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Company Market Share Analysis, 2022
8.3. Strategy Mapping
8.4.公司简介/清单
8.4.1. optimed Medizinische Instrumente GmbH
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Medtronic
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Cerenovus (Johnson & Johnson),
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Acandis GmbH
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. MicroPort Scientific Corporation
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. MicroVention Inc. (Terumo)
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Sino Medical Sciences Technology Inc.
8.4.7.1.概述
8.4.7.2. Financial Performance (Net Revenue)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8.Stryker
8.4.8.1. Overview
8.4.8.2. Financial Performance (Net Revenue)
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. Abbott
8.4.9.1. Overview
8.4.9.2. Financial Performance (Net Revenue)
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. Balt
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives

List of Tables

Table 1. List of secondary sources
Table 2. List of abbreviation
Table 3. Global intracranial stents total addressable market, by region, 2017 - 2030 (USD Million)
Table 4. Global intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 5. Global intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 6. Global intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 7. North America intracranial stents total addressable market, by country, 2017 - 2030 (USD Million)
Table 8. North America intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 9. North America intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 10. North America intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 11. U.S. intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 12. U.S. intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 13. U.S. intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 14. Canada intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 15. Canada intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 16. Canada intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 17. Europe intracranial stents total addressable market, by country, 2017 - 2030 (USD Million)
Table 18. Europe intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 19. Europe intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
表20。欧洲颅内支架总地址able market, by application, 2017 - 2030 (USD Million)
Table 21. UK intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 22. UK intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 23. UK intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 24. Germany intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 25. Germany intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 26. Germany intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 27. France intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 28. France intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 29. France intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 30. Italy intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 31. Italy intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 32. Italy intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 33. Spain intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 34. Spain intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 35. Spain intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 36. Denmark intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 37. Denmark intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 38. Denmark intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 39. Sweden intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 40. Sweden intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 41. Sweden intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 42. Norway intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 43. Norway intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 44. Norway intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 45. Asia Pacific intracranial stents total addressable market, by country, 2017 - 2030 (USD Million)
Table 46. Asia Pacific intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 47. Asia Pacific intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 48. Asia Pacific intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 49. Japan intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 50. Japan intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 51. Japan intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 52. China intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 53. China intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 54. China intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 55. India intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 56. India intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 57. India intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 58. Australia intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 59. Australia intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 60. Australia intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 61. South Korea intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 62. South Korea intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 63. South Korea intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 64. Thailand intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 65. Thailand intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 66. Thailand intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 67. Latin America intracranial stents total addressable market, by country, 2017 - 2030 (USD Million)
Table 68. Latin America intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 69. Latin America intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
表70。拉丁美洲颅内支架addressable market, by application, 2017 - 2030 (USD Million)
Table 71. Brazil intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 72. Brazil intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 73. Brazil intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 74. Mexico intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 75. Mexico intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 76. Mexico intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 77. Argentina intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 78. Argentina intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 79. Argentina intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 80. MEA intracranial stents total addressable market, by country, 2017 - 2030 (USD Million)
Table 81. MEA intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 82. MEA intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 83. MEA intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 84. South Africa intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 85. South Africa intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 86. South Africa intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 87. Saudi Arabia intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 88. Saudi Arabia intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 89. Saudi Arabia intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 90. UAE intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 91. UAE intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 92. UAE intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 93. Kuwait intracranial stents total addressable market, by product, 2017 - 2030 (USD Million)
Table 94. Kuwait intracranial stents total addressable market, by end user, 2017 - 2030 (USD Million)
Table 95. Kuwait intracranial stents total addressable market, by application, 2017 - 2030 (USD Million)
Table 96. Product Pipeline Analysis
Table 97. Estimated number of cases requiring intracranial stenting (in millions), 2021
Table 98. Estimated cost of Procedure by Application, 2021
Table 99. Estimated number of units sold (by region), 2021
Table 100. Estimated ASPs by product segments (Global and Regional), 2021
Table 101. Participant’s overview
Table 102. Financial performance
Table 103. Key companies undergoing expansions
Table 104. Key companies undergoing acquisitions
Table 105. Key companies undergoing collaborations
Table 106. Key companies launching new products/services
Table 107. Key companies undergoing partnerships
Table 108. Key companies undertaking other strategies

List of Figures

Fig. 1 Market segmentation
Fig. 2 Market research process
图3数据三角测量技术
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Intracranial stents total addressable market-TAM analysis
Fig. 10 Methodology for estimating the number of cases requiring intracranial stents
Fig. 11 Methodology for estimating ASP by product segment & regions
Fig. 12 Methodology for estimating total number of units sold, 2022
Fig. 13 Intracranial stents TAM snapshot, 2022 (USD Million)
Fig. 14 Parent market outlook
Fig. 15 Ancillary market outlook
Fig. 16 Market driver relevance analysis (Current & future impact)
Fig. 17 Market restraint relevance analysis (Current & future impact)
Fig. 18 COVID-19 confirmed cases around the world
Fig. 19 Intracranial stents total addressable market, product outlook: Key takeaways, USD million
Fig. 20 Intracranial stents total addressable market: Product movement analysis
Fig. 21 Global embolization coil support intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 22 Global self-expanding stents market, 2017 - 2030 (USD Million)
Fig. 23 Others market, 2017 - 2030 (USD Million)
Fig. 24 Global venous sinus stents market, 2017 - 2030 (USD Million)
Fig. 25 Global balloon-expanding & other stents market, 2017 - 2030 (USD Million)
Fig. 26 Intracranial stents total addressable market, application outlook: Key takeaways, USD million
Fig. 27 Intracranial stents total addressable market: Application movement analysis )
Fig. 28 Global intracranial stenosis market, 2017 - 2030 (USD Million)
Fig. 29 Global brain aneurysm market, 2017 - 2030 (USD Million)
Fig. 30 Others market, 2017 - 2030 (USD Million)
Fig. 31 Intracranial stents total addressable market, end-user outlook: Key takeaways, USD million
Fig. 32 Intracranial stents total addressable market: End user movement analysis
Fig. 33 Global hospitals market, 2017 - 2030 (USD Million)
Fig. 34 Global ambulatory surgical centers market, 2017 - 2030 (USD Million)
Fig. 35 Other end users market, 2017 - 2030 (USD Million)
Fig. 36 Regional marketplace: Key takeaways
Fig. 37 Regional outlook, 2022 & 2030
Fig. 38 North America intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 39 U.S. intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 40 Canada intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 41 Europe intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 42 UK intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 43 Germany intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 44 France intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 45 Italy intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 46 Spain intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 47 Denmark intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 48 Sweden intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 49 Norway intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 50 Asia Pacific intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 51 Japan intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 52 China intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 53 India intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 54 Australia intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 55 South Korea intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 56 Thailand intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 57 Latin America intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 58 Brazil intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 59 Mexico intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 60 Argentina intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 61 MEA intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 62 South Africa intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 63 Saudi Arabia intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 64 UAE intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 65 Kuwait intracranial stents total addressable market, 2017 - 2030 (USD Million)
Fig. 66 Market participation categorization
Fig. 67 Strategy mapping